Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for current CEO Karen ...

The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. CVS Health also warned of disappointing third-quarter ...

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

CVS Health (NYSE: CVS) has appointed a new president and CEO. David Joyner stepped into the role on Oct. 17, succeeding Karen Lynch. Joyner also joined ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

CVS has been struggling with rising medical costs in its Medicare Advantage plans and slumping drugstore sales.

The shift in management is not surprising as the company looks to level set its operations and strategically position itself ...